Hubei Cancer Hospital
Hubei Cancer Hospital
Explore linked clinical trials.29 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Fosrolapitant and Palonosetron for Highly Emetogenic ADC-Induced Nausea and Vomiting in Solid Tumors | Solid Tumor Cancer | Active, not recruiting | Phase 2 | 2026-09-25 | NCT07841210 | |
| CNCMT：a Multi-center, Prospective, Single-arm Study | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, cervix disorder, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorder | Enrolling by invitation | Not applicable | 2026-09-18 | NCT06714084 | |
| Neoadjuvant Therapy With Firmonertinib Combined With Anlotinib and Platinum-Based Doublet Chemotherapy for Resectable EGFR-Mutated NSCLC | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Not yet recruiting | Phase 2 | 2026-09-08 | NCT07807722 | |
| A Study on Combined Low-pass Whole-genome and Methylome Testing of Bloody Nipple Discharge Specimens for Benign-Malignant Differentiation. | Female Urogenital Diseases and Pregnancy Complications, Lactation Disorders, Neoplasms by Site, Skin and Connective Tissue Diseases, Urogenital Diseases, breast cancer, breast disorder, breast neoplasm, galactorrhea, neoplasm, pregnancy disorder, puerperal disorder, skin disorder | Recruiting | Not stated | 2026-07-17 | NCT07250204 | |
| Gut Microbiota and Diarrhea in Breast Cancer Patients Receiving Pyrotinib | Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Neoplasms by Site, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, diarrheal disease, neoplasm, skin disorder | Recruiting | Not stated | 2026-07-16 | NCT07264985 | |
| SIS-Reinforced vs. Conventional Anastomosis for Mid-to-Low Rectal Cancer: A Multicenter RCT on Anastomotic Leak | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal cancer, rectal disorder, rectal neoplasm | Recruiting | Phase 4 | 2026-06-17 | NCT07209787 | |
| INVIGORATE: A Study of QL1706 and Bevacizumab in Advanced First-Line Ovarian Clear Cell Carcinoma | Ovarian Clear Cell Carcinoma | Recruiting | Phase 3 | 2026-05-18 | NCT07002346 | |
| Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, carcinoma, epithelial neoplasm, nasopharyngeal carcinoma, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic disease | Active, not recruiting | Phase 3 | 2026-05-11 | NCT05780372 | |
| PRL3-Zumab in Patients With Advanced Solid Tumors | Advanced Malignant Solid Tumor | Active, not recruiting | Phase 2 | 2026-04-23 | NCT07541001 | |
| Observational Study of Gut Microbiota in Abemaciclib-Treated Patients With and Without Diarrhea | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, hormone receptor-positive breast cancer, neoplasm, skin disorder | Recruiting | Not stated | 2026-04-03 | NCT07264998 | |
| DIEP Flap Breast Reconstruction: Perioperative Biomarkers and Outcomes | Inflammation, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, cardiovascular disorder, ischemia reperfusion injury, neoplasm, skin disorder, vascular disorder | Recruiting | Not stated | 2026-04-03 | NCT07263347 | |
| A Trial for Advanced Leiomyosarcoma With Human Organoid-guided Personalized Efficacy | Advanced Leiomyosarcoma | Enrolling by invitation | Not applicable | 2026-02-12 | NCT07405346 | |
| Study on the Relationship Between Opioid Drugs and the Therapeutic Efficacy of Immunotherapy | Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, agnosia, nervous system disorder, perceptual disorders | Not yet recruiting | Not stated | 2025-09-23 | NCT07188857 | |
| Impact of Splenectomy on the Efficacy of Targeted Therapy and Immunotherapy in Unresectable HCC Patients With Cirrhotic Portal Hypertension | Unresectable Hepatocellular Carcinoma | Recruiting | Not stated | 2025-08-15 | NCT06280313 | |
| SBRT, Chemotherapy, and AK112 Neoadjuvant Therapy for Luminal-type Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 2 | 2025-07-02 | NCT06402435 | |
| Brain Alterations Based on Multiplex MR Imaging in Nasopharyngeal Carcinoma Patients After Treatment, and Their Correlation With Clinical Cognitive Scores. | Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Cognition Disorders, Cognitive Dysfunction, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Head and Neck Neoplasms, Hemic and Lymphatic Diseases, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Lysosomal Storage Diseases, Nervous System, Neoplasms by Histologic Type, Neoplasms by Site, Niemann-Pick disease, Niemann-Pick disease type A, Nutritional and Metabolic Diseases, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, brain disorder, carcinoma, central nervous system disorder, cognitive disorder, epithelial neoplasm, hereditary disease, histiocytosis, inborn errors of metabolism, lymphatic system disorder, lysosomal lipid storage disorder, lysosomal storage disease, metabolic disease, nasopharyngeal carcinoma, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, nervous system disorder, non-Langerhans cell histiocytosis, otorhinolaryngologic disease, psychiatric disorder, sphingolipidosis | Active, not recruiting | Not stated | 2025-06-11 | NCT07011329 | |
| Investigating the Effects of Different Incision Types on Aesthetic Outcomes and Incision-related Complications After Breast Reconstruction Surgery | Breast Neoplasm Female | Enrolling by invitation | Not stated | 2025-03-17 | NCT06258863 | |
| Orlistat Overcoming Third-generation EGFR-TKI Resistance | Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, adenocarcinoma, carcinoma, epithelial neoplasm, lung adenocarcinoma, lung neoplasm, neoplasm, respiratory tract neoplasm | Not yet recruiting | Phase 2 | 2025-02-12 | NCT06818955 | |
| Effect of Different Surgical Approaches of Granulomatous Mastitis | Female Urogenital Diseases and Pregnancy Complications, Skin and Connective Tissue Diseases, Urogenital Diseases, breast disorder, granulomatous mastitis, mastitis, pregnancy disorder, puerperal disorder, skin disorder | Recruiting | Not applicable | 2024-12-02 | NCT06712524 | |
| SBRT, Chemotherapy, and AK104 Neoadjuvant Therapy for Triple-negative Breast Cancer (TNBC) | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 2 | 2024-12-02 | NCT06401005 | |
| Palliative Hepatectomy Combined With Targeted Therapy and Immunotherapy for Advanced Hepatocellular Carcinoma | Advanced Hepatocellular Carcinoma | Recruiting | Phase 1 | 2024-06-24 | NCT06470256 | |
| Primary Tumor Radiotherapy Omitting CTV for Patients With Advanced NSCLC Responded to Immunotherapy and Chemotherapy | Advanced Non-Small Cell Squamous Lung Cancer; Immunotherapy; Radiotherapy | Recruiting | Not applicable | 2024-03-15 | NCT06037733 | |
| Single-drug Chemotherapy Plus Immunotherapy in Metastatic Non-small Cell Lung Cancer Elderly Patients | Neoplasms by Site, Thoracic Neoplasms, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 2 | 2024-03-15 | NCT06032052 | |
| Omitting CTV for Locally Advanced NSCLC Responded to Immunotherapy and Chemotherapy | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Not applicable | 2024-03-15 | NCT06020430 | |
| Ondanstron Weekly vs Every 3 Weeks for Prevention of Nausea and Vomiting Induced by Chemotherapy Combined With PD-1 Blockade | Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, Vomiting | Recruiting | Not applicable | 2024-02-29 | NCT06080880 |